Education Education Bill Tracking DatabaseIn 2010, 2011, and 2016 there was no COLA payable at all and, in 2017, the COLA was just 0.03 percent. Likewise, in 2018, the COLA was 2 percent, but rising Part B premiums consumed the entire increase for roughly half of all beneficiaries..The panel discussed the following options for strengthening Social Security, among others: updating the benefit formula for low-income workers, modifying the annual cost-of-living adjustment to make it more accurate, increasing survivors' benefits, and creating caregiver credits for those who support aging parents. However, the focus of Wednesday's hearing seemed to be on addressing the insolvency of the Social Security Disability Insurance program..Despite the slowing of the CPI, earlier this year, Medicare actuaries estimated that the base Part B premium paid by most seniors will climb about 8%, from .90 per month to 9.10, starting next January. … Continued
States And Covid 19 Vaccine Distribution Oas Episode 119The period covered by the Notch is a major area of dispute. When benefits are represented on a chart, the disparity forms a deep "V" notch. Benefits plunged from a peak for retirees born in 1916 and hit the lowest part of the "V" for those who were born in the years 1920-2Benefits began to rise for those born in 1922 until they became level with other retirees, starting with those born in 192See illustration below..Currently, Social Security COLAs are based on the way young, urban workers spend their money not the way Social Security beneficiaries do. As a result, goods and services like gasoline and electronics are weighted more heavily than housing and health care two of the fastest growing costs for older Americans. If the COLA were actually based on the way retirees spend their money using the more accurate CPI-E, Social Security beneficiaries would not be receiving a 0.3 percent COLA in 2017, they would be receiving a 2.1 percent increase, according to new data from the Bureau of Labor Statistics..Sudden price spikes in older drugs are putting patients at risk of going without vital medicine. A new report by the U.S. Senate Special Committee on Aging uncovered an insidious business model that's leading to monopoly pricing power and astronomical price increases. … Continued
